Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Therapeutics
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Breast Cancer Vaccine
      • Introduction
      • Markets
      • Science
      • Collaborators
  • Diagnostics
    • Cchek™
    • Markets
    • Science
    • Collaborators
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Presentations
    • Publications
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

ITUS Corporation Announces Proposed Public Offering of Common Stock

May 10, 2017

ITUS Receives Notice of Allowance for First Cancer Technology Patent

May 10, 2017

ITUS Extends its Collaboration with Virtua Healthcare System

May 9, 2017

ITUS Presents at American Association of Cancer Research Conference

April 6, 2017

ITUS Announces Closing of Rights Offering

April 4, 2017

ITUS Early Cancer Detection Biomarker Study Expands to Include Abramson Cancer Center Researchers

March 20, 2017

ITUS Rights Offering Materials Available for Shareholders of Record

March 13, 2017

The Delaware Valley Urology Cancer Treatment Center Joins ITUS Early Cancer Detection Biomarker Study

March 7, 2017

ITUS Announces February 24, 2017 is the Ownership Day for the ITUS Rights Offering

February 23, 2017

ITUS Corporation to Present Data at the American Association of Cancer Research National Conference

February 21, 2017

RSS
  • « Previous
  • 1...
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Dec 2, 2019

Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium

Read More...
Nov 26, 2019

Anixa Biosciences Announces Genesis Research to Join Cchek™ Prostate Cancer Study

Read More...
Nov 22, 2019

Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek™ Prostate Cancer Study

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.

Copyrights © 2019 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap